Global Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market Size By Type (Hemostats, Internal Tissue Sealants), By Application (Hospitals, Clinics & Trauma Centers), By Geographic Scope And Forecast

Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market Size And Forecast

Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market size was valued at USD 5,178.84 Million in 2023 and is projected to reach USD 9,087.23 Million by 2030, growing at a CAGR of 7.33% from 2024 to 2030.

The surgical hemostats are agents that prevent bleeding during surgery by encouraging coagulation at the wound site. They are also frequently employed to grip and secure tissue and superficial fascia during surgical procedures. They are ideal for exposing, probing, and viewing the deeper parts of a surgical site. Internal tissue sealants are chemicals that bind tissues together, promoting wound closure and preventing leakage. The skin, internal organs, and blood arteries are all examples of damaged tissues. Sealants, which can be used in conjunction with mechanical procedures such as sutures and staples, serve to decrease blood loss and prevent leaks. Adhesion barriers are materials used to decrease tissue adhesions and prevent undesirable adhering between internal organs and surfaces following surgery. These medical tools help to improve surgical outcomes by treating bleeding, closing tissues, and preventing adhesions.

Global Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market Definition

Blood loss during surgery occurs as a result of blood artery disruption, and coagulating the blood is critical to preventing excessive bleeding. Hemostasis is the production of blood clots at the point of damage. Failure to employ standard wound closure agents is a major cause of blood loss in surgery. This has resulted in the demand for effective hemostatic drugs during surgical procedures. Hemostats are surgical agents that increase coagulation in order to control bleeding during surgery.

Different hemostatic techniques may be used depending on the type of injury, and they can be made of materials such as gelatin, cellulose, oxidized regenerated collagen, and others. Hemostats come in a number of compositions, including sheet and pad, matrix and gel, powder, and sponge hemostats, and are employed in a wide range of surgical applications, from general to neurological surgery.

Global Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market Overview

The healthcare sector is growing rapidly around the world. Although the average hospital stay for a single patient has decreased significantly over the last few decades, from 7 to 5-6 days, the total number of hospital admissions has increased in the last 5-6 years. According to the American Hospital Association, the total number of hospitals in the LIS in 2019 was 6,090. According to the Department of Industrial Policy and Promotion (DIPP), India’s hospitals and diagnostic centers have garnered USD 6 billion in foreign direct investment (FDI).

However, there are several factors that can have a negative impact on the market growth. The cost of treatment associated with surgical hemostats, internal tissue sealants, and adhesion barriers is extremely high. Its high cost may limit market growth. According to research published in the Journal of Vascular Surgery in June 2021, individuals may undergo further surgeries to prevent postoperative adhesions, which increases their medical costs and physical stress. The cost of agents varies based on the ingredients utilized. Using an adhesion barrier in laparoscopic operations raises expenses by about $162. This limitation can be avoided by implementing updated government reimbursement policies that can help patients financially.

The market has a positive future outlook due to the rising demand for minimally invasive surgical treatments. To achieve effectiveness with these treatments, effective hemostats, tissue sealants, and adhesion barriers must be used. The key driver driving market growth and development is the increased incidence of chronic diseases such as diabetes, obesity, and cardiovascular disease. Minimally invasive techniques offer a less intrusive option for people with chronic conditions that frequently necessitate surgical intervention. For example, minimally invasive operations are frequently utilized in bariatric surgery, which treats obesity and associated disorders.

Global Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers MarketSegmentation Analysis

The Global Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market is Segmented on the basis of Type, Application, and Geography.

Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market, By Type

• Hemostats
• Internal Tissue Sealants
• Adhesion Barriers

Based on Type, the market is segmented into Hemostats, Internal Tissue Sealants, and Adhesion Barriers. The hemostats segment held the largest market share in 2022. Changing eating habits and lifestyles have resulted in a significant increase in the incidence of obesity and other diseases such as diabetes, cancer, and cardiovascular disease, which is the primary reason for the increase in surgical procedures performed annually around the world. Hemostat medicines help limit blood loss, close surgical sites, and heal wounds during many surgeries. Due to the demonstrated benefits of hemostat products and increasing awareness, the use of hemostatic agents in surgical operations is likely to rise during the projection period.

Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market, By Application

• Hospitals
• Clinics & Trauma Centers
• Ambulatory Surgical Centers

Based on Application, the market is segmented into Hospitals, Clinics & Trauma Centers, and Ambulatory Surgical Centers. The hospitals segment held the largest market share in 2022. The increased availability of surgical hemostat procedures in hospitals supports market expansion. These techniques are essential in hospitals for a variety of surgical specialties. Whether in minor surgeries or routine procedures, these medicines help to control bleeding, lowering surgical time and blood loss. Hospitals use a variety of hemostatic drugs to address a wide range of clinical conditions, with the goal of improving patient outcomes and increasing surgical team efficiency.

Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

On the basis of Regional Analysis, the Global Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Based on the geography, North America accounted for the largest market share in 2022. North America has made significant technological advances in many procedures, resulting in a large number of surgeries in the region and a positive impact on demand. The rapid improvement of technology in the healthcare industry, as well as the large number of surgeries conducted in the United States, are primary factors driving demand for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers. The healthcare industry in the United States is at the forefront of technical innovation, introducing innovative surgical techniques and procedures continuously. This includes minimally invasive operations, robotic-assisted surgeries, and other advanced techniques that require specific hemostats, sealants, and adhesion barriers for optimal outcomes.

Key Players

The “Global Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market” study report will provide valuable insight with an emphasis on the global market. The Global Surgical Hemostats, Internal Tissue Sealants And Adhesion Barriers Market is highly fragmented with the presence of a few well-established players and several medium players. Some of the major companies include Pfizer Inc., Johnson & Johnson, Sanofi S.A., Becton, Dickinson and Company, Baxter International Inc., B. Braun SE, Teleflex Incorporated, Integra Lifesciences, Artivion, and Cohera Medical Inc. among others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, benchmarking and SWOT analysis.

Report Scope

Top Trending Reports